Latest H5N1 clinical trials Stories
DUBLIN, March 20, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/n8dfqv/china_influenza) has announced the addition of the "China
Somali Americans develop twice the antibody response to rubella from the current vaccine compared to Caucasians in a new Mayo Clinic study on individualized aspects of immune response.
Study shows vaccine provides protection against EV71-associated hand, foot and mouth disease in infants and young children BEIJING, Feb.
SINGAPORE and ZURICH, January 29, 2014 /PRNewswire/ -- Singapore's Agency for Science, Technology and Research (A*STAR) and Switzerland's Cytos Biotechnology AG today announced
The results show that Colby’s JVRS-100 adjuvant, when used in combination with an influenza virus vaccine, generates enhanced immunity and superior protection of elderly monkeys when challenged
- An imitative word; an onomatopoetic word.